The Atopic Dermatitis Countdown: Ready, Set, Go!
The University of Chicago via Independent
-
26
-
- Write review
Overview
The goal of this activity is to improve the identification and treatment of patients who are candidates for systemic or biologic agents for atopic dermatitis, including incorporation of new therapies.
Educational Partner: Medscape, LLC
Medium: Online Module
Commercial Support: Support for this activity has been provided through and independent educational grant from LEO Pharma A/S and LEO Pharma Inc.
Syllabus
After completing this activity, participants will be able to:
- Have increased knowledge regarding the
- Burden of atopic dermatitis;
- Role of interleukin (IL)-13 in the pathophysiology of atopic dermatitis;
- Current evidence for new and emerging biologic agents for the treatment of atopic dermatitis.